North America Scar Treatment Market Growth Accelerated By Scar Treatment Gaining Preference For Post Traumatic Scar Management



Scar treatment products includes scar gel, scar sheets, patches, creams etc which helps in fading scars, redness and restoring skin texture. These products are clinically proven to reduce the appearance of scars like acne, post-surgical, burns etc by speeding up skin renewal process, managing scar formation and inflammation.

The global North America scar treatment market is estimated to be valued at US$ 4,348.7 million in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:

 Scar treatment gaining preference for post traumatic scar management has been one key trend contributing to market growth. Various traumatic injuries and incidents leading to scarring has fueled the demand for scar treatments. Also, increasing awareness about new scar treatment products and their efficacy in scar reduction has accelerated their adoption. Growing preference for minimally invasive procedures and topical scar treatments over surgical procedures for scar management, has boosted the North America scar treatment market.

Segment Analysis
The North America scar treatment market is dominated by the prescription scar treatment sub-segment. This sub-segment currently holds the largest market share due to the availability of US Food and Drug Administration (FDA) approved prescription products and increasing awareness about their efficacy in treating scars. Topical medications such as creams, gels, and lotions are extensively prescribed by dermatologists and other healthcare professionals for the treatment of scars like hypertrophic and keloid scars.

Key Takeaways
The Global North America Scar Treatment Market Size  is expected to witness high growth over the forecast period of 2023 to 2030. The global North America Scar Treatment Market is estimated to be valued at US$ 4,348.7 Mn in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023-2030.

Regional analysis
The United States holds the dominant share in the North American scar treatment market and is expected to witness the fastest growth during the forecast period. This is attributed to the presence of major market players, high healthcare expenditure, and rising awareness about scar treatment options in the country. Canada is also projected to exhibit lucrative growth prospects due to the increasing adoption of novel scar treatment technologies across medical facilities.

Key players
Key players operating in the North America scar treatment market are ScarAway, Thrive Aesthetics MN, HRA Pharma, MARLO WHITNEY, Smith & Nephew Inc, Merz Therapeutics, Enaltus LLC, Oculus Innovative Sciences, Inc, CCA Industries, Bausch Health Companies Inc., Candela Medical, Perrigo Company plc, Sonoma Pharmaceuticals, Inc., Hologic, Inc., Johnson & Johnson Surface Treatment, Inc., Quantum Health, AVITA Medical, Revitol Corp, Scarguard labs, Lumenis Be Ltd, Cynosure, GC Aesthetics, Sientra, Inc, SkinCeuticals, Cimeosil.com, Honeydew Products, 3V Sigma USA Inc., Syneron Medical Ltd.

Get more insights on this topic:

Comments

Popular posts from this blog

Eyewear Market Is Estimated To Witness High Growth Owing To the Growing Demand for Prescription Eyewear

The Mobile Computed Tomography Is The Fastest Growing Segment Fueling The Growth Of Computed Tomography Market

The Electronic Warfare Market Will Grow At Highest Pace Owing To Rising Adoption Of Advanced Electronic Warfare Systems In Defense Sector